Our current study represents an inaugural report delineating the role of MKRN2 in restraining ccRCC progression and promoting its apoptosis through PPP2CA-dependent deactivation of Wnt signaling. The gene discussed is MKRN2; the disease is nonpapillary renal cell carcinoma.